G Medical Innovations Holdings Ltd (GMVD) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access GMVD Annual Cash Flow →
This cash flow overview for G Medical Innovations Holdings Ltd spans from Dec 31 2021 to Dec 31 2022, illustrating how cash generation and usage have shifted across recent reporting periods.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2022)
12 Months
0 0 0 (Dec 31 2021)
Operating Activities
Income-13.94
Depreciation & amortization0.00
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Adjustments For Gain Loss On Disposals PropertyPlant And Equipment0.02
Share-based Compensation0.00
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Adjustment For Increase Decrease In Revaluation Of Restricted Deposit-
Adjustments For Sharebased Payments-
Adjustments For Increase Decrease In Forgiveness Of P P P Loan-
Adjustments For Decrease Increase In Accrued Income Including Contract Assets-
Adjustments For Increase Decrease In Change In Fair Value Of Convertible Securities-
Adjustments For Decrease Increase In Other Operating Receivables-
Adjustments For Decrease Increase In Inventories-
Adjustments For Increase Decrease In Trade Account Payable-
Adjustments For Increase Decrease In Other Operating Payables-
Adjustments For Decrease Increase In Accrued Interest On Loan From Major Shareholder-
Finance Income Received Classified As Operating Activities-
Loss From Disposal Equipment-
Amount Charged In Respect Of Convertible Loans-
Finance Income Expenses From Reinsurance Contracts Held Excluded From Profit Or Loss Net Of Tax-
Income taxes0.00
Adjustments For Decrease IncreaseIn Derivative Financial Assets0.00
Accounts Receivable0.00
Adjustments For Decrease IncreaseIn Trade Account Receivable0.09
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets0.00
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-31.95
Discontinued operations0.00
Net Cash flow from Operating Activities-18.48
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.03
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Purchase Of Other Longterm Assets Classified As Investing Activities-
Withdrawal Of Restricted Deposit-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.38
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net-2.12
Discontinued operations0.00
Net Cash Flow from Investing Activities-2.12
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.02
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net20.62
Increase Decrease In Cash And Cash Equivalents-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities14.86
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-18.45
Total Cash Flow6.03
4 historic quarters locked

Sign in to unlock the full G Medical Innovations Holdings Ltd cash flow history.

About G Medical Innovations Holdings Ltd Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001213900-23-040099

Figures are derived from filed reports and may be restated. Historical data is subject to revision.